| abstract |
"compound, use thereof, pharmaceutical composition, and, process for treating a patient suffering from a disorder that is susceptible to treatment with a thrombopoietin agonist." Peptides and compounds that bind to and activate the thrombopoietin receptor are described. such peptides and compounds are useful in methods for treating hematological disorders and particularly thrombocytopenia resulting from chemotherapy, radiation therapy or bone marrow transfusions, as well as in diagnostic procedures employing labeled peptides and compounds. |